DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» PKMYT1
PKMYT1
Systematic Screening for Potential Therapeutic Targets in Osteosarcoma Through a Kinome-Wide CRISPR-Cas9 Library
The Combination of the PARP Inhibitor Olaparib and the Wee1 Inhibitor AZD1775 As a New Therapeutic Option for Small Cell Lung Cancer
Bioinformatics-Based Screening of Key Genes for Transformation of Liver
NIH Public Access Author Manuscript J Theor Biol
Small-Molecule Binding Sites to Explore New Targets in the Cancer Proteome
Ser 15 of WEE1B Is a Potential PKA Phosphorylation Target in G2/M Transition in One-Cell Stage Mouse Embryos
Biomarkers, Master Regulators and Genomic Fabric Remodeling in a Case of Papillary Thyroid Carcinoma
Activation of Diverse Signalling Pathways by Oncogenic PIK3CA Mutations
Supplementary Information
Investigations on the Human Myt1 Kinase: Substrate Studies, Assay Development and Inhibitor Screening Alexander Rohe
Brain-Restricted Mtor Inhibition with Binary Pharmacology 2 3 Ziyang Zhang1, Qiwen Fan2,3, Xujun Luo2,3, Kevin J
Defining the KRAS-Regulated Kinome in KRAS-Mutant Pancreatic Cancer
PKMYT1 Is a Computationally Predicted Target for Kidney Cancer
Genome-Wide CRISPR-Cas9 Screen Reveals Selective Vulnerability of ATRX-Mutant Cancers to WEE1 Inhibition Junbo Liang1, Hong Zhao2,3, Bill H
Comparative Gene Expression Analysis to Identify Common Factors in Multiple Cancers
FGFR4 Regulates Tumor Subtype Differentiation in Luminal Breast Cancer and Metastatic Disease
The Roles of Cyclin-Dependent Kinases in Cell-Cycle Progression and Therapeutic Strategies in Human Breast Cancer
Kinome Expression Profiling to Target New Therapeutic Avenues in Multiple Myeloma
Top View
PKMYT1 Antibody
Pdf Download Poster (1.26
Download a Pdf with a List of Active Protein Kinases Available From
Supplemental Table-1
A WEE1 Family Business: Regulation of Mitosis, Cancer Progression, and Therapeutic Target
Preclinical Evaluation of the WEE1 Inhibitor MK-1775 As Single-Agent Anticancer Therapy
PKMYT1 Aggravates the Progression of Ovarian Cancer by Targeting SIRT3
S41467-020-15428-0.Pdf
Understanding and Exploiting MYCN Addiction in High-Risk Neuroblastoma Using the Example of CDK13
Coding Mutations in NUS1 Contribute to Parkinson's Disease
UNIVERSITY of CALIFORNIA, SAN DIEGO Modeling Nonlinear Behavior of Dynamic Biological Systems a Dissertation Submitted in Partia
Will Makedon Luonnonton Moviu
Profiling Data
Regulation of G2/M Transition by Inhibition of WEE1 and PKMYT1 Kinases
A Quantitative Atlas of Mitotic Phosphorylation
Pan-Cancer Analysis of Human Kinome Gene Expression and Promoter DNA Methylation Identifies Dark Kinase Biomarkers in Multiple C
Scanmaxsm Kinase Assay Panel
Revealing Different Roles of the Mtor-Targets S6K1 and S6K2 in Breast Cancer by Expression Profiling and Structural Analysis